1421 |
CTO Revascularization 2022: Guidelines and Concept Change |
Jung-Min Ahn |
Nov. 02. 22 |
1420 |
How to Perform the Optimal Two Stenting in Non-LM Bifurcation? |
Do-Yoon Kang |
Nov. 02. 22 |
1419 |
How to Perform the Optimal Provisional Stenting in Non-LM Bifurcation? |
Ho Lam |
Nov. 02. 22 |
1418 |
Physiologic Approach For Non-LM Bifurcation Disease |
Jung-Min Ahn |
Nov. 02. 22 |
1417 |
Non-LM Bifurcation Revascularization 2022: Guidelines and Concept Change |
Seung-Jung Park |
Nov. 02. 22 |
1416 |
How to Manage LM ISR? |
Sunao Nakamura |
Nov. 02. 22 |
1415 |
Optimal MSA for LM Crush Technique: New Criteria from AMC |
Do-Yoon Kang |
Nov. 02. 22 |
1414 |
Unmet Need for FFR in LM PCI |
Jung-Min Ahn |
Nov. 02. 22 |
1413 |
LM Revascularization 2022: Guidelines and Concept Change |
Duk-Woo Park |
Nov. 02. 22 |
1412 |
PCSK9 Inhibitor: Effect of Alirocumab on CV Events and Mortality After ACS |
Hanbit Park |
Apr. 08. 22 |